Orbus Therapeutics
Orbus Therapeutics is a US-approved specialty pharmaceutical manufacturer. Reserve Meds supports cross-border NPP access to Orbus Therapeutics products.
Drugs from Orbus Therapeutics supported via NPP
| Brand | Generic | Category | Indication |
|---|---|---|---|
| Iwilfin | eflornithine tablets | Oncology (Neuroblastoma) | High‑risk neuroblastoma maintenance |
How NPP access to Orbus Therapeutics products works
Reserve Meds sources Orbus Therapeutics products from DSCSA-compliant US specialty wholesalers, not from parallel-import channels. All supply is US-FDA-provenance.
Not affiliated with Orbus Therapeutics
Reserve Meds is an independent NPP operator. We are not a subsidiary, affiliate, or authorised distributor of Orbus Therapeutics.